Filter
1533
Filtered Results: 1533
Text search:
intellectual
disability
Featured
Recommendations
162
New Publications
325
Language
Document type
No document type
934
Studies & Reports
206
Guidelines
175
Manuals
107
Strategic & Response Plan
60
Training Material
32
Fact sheets
8
Situation Updates
7
Resource Platforms
2
Infographics
1
Online Courses
1
Countries / Regions
Global
94
India
40
South Africa
39
Nepal
29
Kenya
27
Ethiopia
24
Western and Central Europe
23
Bangladesh
22
Uganda
22
Ukraine
19
Lebanon
19
Ghana
18
Syria
17
Zambia
17
Myanmar / Burma
16
Malawi
15
Africa
15
Latin America and the Carribbean
15
Philippines
14
Cambodia
14
South–East Asia Region
14
Rwanda
13
Indonesia
12
Namibia
11
Nigeria
10
Tanzania
10
Mozambique
9
Thailand
8
Lesotho
8
Sierra Leone
8
Cameroon
8
Vietnam
8
Eastern Europe
8
Paraguay
7
Asia
6
Eastern Europe and Central Asia
6
South Sudan
6
Burkina Faso
5
Afghanistan
5
Zimbabwe
5
Western Pacific Region
5
Brazil
5
Liberia
5
Benin
4
China
4
Iran
4
Laos
4
Jordan
4
Middle East and North Africa
4
Somalia
4
Pakistan
4
Congo, Democratic Republic of
3
West and Central Africa
3
East and Southern Africa
3
Bolivia
3
Russia
3
Sudan
3
Yemen
3
Central African Republic
3
Botswana
3
Iraq
3
Eswatini/ Swaziland
3
North Macedonia
2
Senegal
2
Estonia
2
Peru
2
Malaysia
2
Venezuela
2
Lithuania
2
Azerbaijan
2
Sri Lanka
2
Egypt
2
Palestine
2
Guatemala
2
Switzerland
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
Serbia
1
Kazakhstan
1
Albania
1
Canada
1
Singapore
1
Kyrgyzstan
1
Qatar
1
Bulgaria
1
USA
1
Haiti
1
Croatia
1
Germany
1
Saudi Arabia
1
Turkmenistan
1
Japan
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Bosnia and Herzegovina
1
Argentina
1
Moldova
1
Djibouti
1
Mali
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
417
Public Health
112
Women & Child Health
108
Clinical Guidelines
106
Key Resources
75
Capacity Building
40
Pharmacy & Technologies
7
Toolboxes
Disability
415
Mental Health
258
COVID-19
77
NTDs
55
HIV
47
Conflict
42
Planetary Health
38
Caregiver
35
TB
32
NCDs
25
Global Health Education
24
Rapid Response
18
Refugee
14
Health Financing Toolbox
14
Zika
11
Pharmacy
10
AMR
10
Natural Hazards
9
Malaria
7
Ebola & Marburg
6
Social Ethics
3
Specific Hazards
2
2.0 Rapid Response
2
Cholera
1
Polio
1
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Public health emergencies, including pandemics, highlight the need for health systems and services that are prepared, resilient and ready to respond to health security threats. Endorsed by Member States in 2023, the Asia Pacific Health Security Action Framework (APHSAF) is designed to engage m...
Deeply concerned by the morbidity and mortality caused by the COVID-19 pandemic, the negative impacts on physical and mental health and social well-being, the negative impacts on economies and societies and the consequent exacerbation of inequalities within and between countries.
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
World malaria report 2024
recommended
New data from the WHO reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated ...
The role of evidence in the journey towards universal health coverage is paramount. Financial risk protection monitoring, the major focus of this report, informs where the WHO African Region stands in reducing the financial hardship people face due to health expenses. This report details the status ...
There has never been a more critical moment to invest in WHO, and strengthen the unique role it plays in global health. Now is the time to sustainably finance WHO and invest in a healthy return for all.
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks
recommended
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
The objectives of this guideline are the same as those of the 2011 edition, namely to provide evidence-based normative guidance on interventions to improve adolescent morbidity and mortality by reducing the chances of early pregnancy and its resulting poor health outcomes. The specific objectives of...
Report of a virtual meeting 21–23 June 2022
Preferred product characteristics and clinical development considerations
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
These guidelines promote the delivery of people-centred health services for STIs by providing evidence-based recommendations related to decentralization, integration, task sharing and digital health. These recommendations complement existing WHO guidelines for STI testing, treatment and management, ...
This operational guidance provides a structured approach to support countries in sustaining priority services for HIV, viral hepatitis and sexually transmitted infections in the context of reduced external funding. The guidance is intended for national governments, public health programmes, communit...
Buruli ulcer (BU) is a skin-related neglected tropical disease (skin NTD) caused by infection with
Mycobacterium ulcerans. BU is the third most common mycobacterial disease after tuberculosis and leprosy
in people who are not immunocompromised. The infection manifests in non-ulcerative forms as no...
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-preventable diseases. This responsibility has been translated into firm commitments in February 2016, t...
